Sign In
Buy SRPT
$16.24
-0.0100 (-0.0615%)
At Close: Jun 03, 2026
Sarepta Therapeutics to Showcase Data from its Gene Therapy and RNA Platforms at World Muscle Society 2021 Virtual Congress
08:30am, Tuesday, 14'th Sep 2021
CAMBRIDGE, Mass., Sept. 14, 2021 (GLOBE NEWSWIRE) -- Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, will present at the World Muscle Society 2021
Sarepta Therapeutics, Inc. (SRPT) CEO Doug Ingram Presents at Morgan Stanley 19th Annual Global Healthcare Conference (Transcript)
Sarepta Therapeutics to Present at Upcoming Investor Conferences
04:30pm, Tuesday, 07'th Sep 2021
CAMBRIDGE, Mass., Sept. 07, 2021 (GLOBE NEWSWIRE) -- Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, today announced that senior management will p
How Does Sarepta's Stock Performance In The Current Crisis Compare With That In 2008?
09:00am, Tuesday, 07'th Sep 2021
We believe that Sarepta Therapeutics stock, a biotech company focused on the discovery and development of RNA-targeted therapeutics and gene therapy for the treatment of rare diseases, is a good bu
Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
05:57pm, Tuesday, 31'st Aug 2021
CAMBRIDGE, Mass., Aug. 31, 2021 (GLOBE NEWSWIRE) -- Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, granted equity awards on August 31, 2021 that
4 Underpriced Healthcare Stocks That Wall Street Adores
11:46am, Thursday, 19'th Aug 2021
A drug maker, two insurers, and a medical-device company pass our screen of healthcare concerns with high analysts ratings and upside potential.
Sarepta Therapeutics, Inc. (SRPT) CEO Doug Ingram on Q2 2021 Results - Earnings Call Transcript
10:29pm, Wednesday, 04'th Aug 2021
Sarepta Therapeutics, Inc. (SRPT) CEO Doug Ingram on Q2 2021 Results - Earnings Call Transcript
– Limb-girdle muscular dystrophy type 2A is the most common form of LGMD, accounting for a third of LGMD diagnoses
Sarepta Therapeutics's Earnings: A Preview
10:54am, Tuesday, 03'rd Aug 2021
Sarepta Therapeutics (NASDAQ:SRPT) will be releasing its next round of earnings this Wednesday, August 04. For all of the relevant information, here is your guide for Wednesday's Q2 earnings announcem
Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
05:42pm, Friday, 30'th Jul 2021
CAMBRIDGE, Mass., July 30, 2021 (GLOBE NEWSWIRE) -- Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, granted equity awards on July 30, 2021 that we
Sarepta Therapeutics to Announce Second Quarter 2021 Financial Results and Recent Corporate Developments on August 4, 2021
08:30am, Wednesday, 28'th Jul 2021
CAMBRIDGE, Mass., July 28, 2021 (GLOBE NEWSWIRE) -- Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, will report second quarter 2021 financial resu
Sarepta, Vertex, Neurocrine: There's Deep Value In These Beaten Down Healthcare Stocks
10:00am, Thursday, 01'st Jul 2021
Our theme of Out Of Favor Health Care Stocks includes healthcare and pharma names that are seeing a disconnect between their financial performance and stock price returns. Specifically, the theme filt
Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
06:41pm, Wednesday, 30'th Jun 2021
CAMBRIDGE, Mass., June 30, 2021 (GLOBE NEWSWIRE) -- Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, granted equity awards on June 30, 2021 that we
Sarepta Therapeutics, Inc. (SRPT) CEO Doug Ingram Presents at Bank of America Securities 2021 Napa BioPharma Virtual Conference (Transcript)
05:04pm, Wednesday, 16'th Jun 2021
Sarepta Therapeutics, Inc. (SRPT) CEO Doug Ingram Presents at Bank of America Securities 2021 Napa BioPharma Virtual Conference (Transcript)
Tuesday Analyst Upgrades and Downgrades: Campbell Soup, Exact Sciences, Exelixis, Spirit Airlines, Sarepta, ZTO and More
09:11am, Tuesday, 15'th Jun 2021
Tuesday's futures were fairly positive after a somewhat mixed start to the week.
